Discovering the molecular story of exceptional people

We bring the fine-grain data needed to bridge the gap
between genetic determinants and actionable insights.
100x100 global health study by Owkin aims to collect stories, environmental features and DNA of people with a very unique phenotype such as an exceptional response to therapy. Thanks to our unique technology, our team integrates the most recent technics of artificial intelligence to system biology.
We unravel and compare the molecular complex stories of these patients that leads from SNP identification to these unique phenotypes. It is also powerful at a cohort level, as finding common chapters among these patient's stories can help finding combinations new therapeutic targets in unmet medical needs.